Sarcouncil Journal of Medical Sciences

Abstract: Background: The endoscopic third ventriculostomy (EVT) is widely regarded as the optimal surgical technique for treating hydrocephalus, regardless of its underlying cause. Objective: This study aims to evaluate the effectiveness of endoscopic third ventriculostomy in the treatment of hydrocephalus patients. Patients and Methods: Clinical data was collected from patients aged between 20 and 60 who underwent the endoscopic third ventriculostomy procedure at different hospitals in Iraq between July 15th, 2022, and August 18th, 2023. The study assessed the success and failure rates of the procedure, as well as the 24-month survival outcomes, using the Kaplan-Meier method. Results: Among all patients, there were 20 cases of infection, with the highest rate observed in patients aged between 50 and 60. Males accounted for 35 cases, surpassing females who had 20 cases. The follow-up period for surgical results was five years, with an average hospital stay of 7 days. Three patients exhibited high heart rate, while four patients had high blood pressure. Out of the total 55 patients, 51 experienced successful ETV surgical outcomes, while four were unsuccessful. Postoperative complications were recorded in eight patients. Conclusion: The endoscopic third ventriculostomy (EVT) technique is the preferred alternative to ventriculoperitoneal shunt for the treatment of hydrocephalus patients.